In transgenic mouse models of AD, expressing palmitoylation‐deficient forms of APH1aL (an isoform of APH‐1) and Nicastrin resulted in significantly reduced deposition of Aβ aggregates in the frontal cortex compared with mice expressing wild‐type forms of these subunits. Here, NCSTN is linked to Alzheimer disease.